No Data
No Data
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025
Barrington Reaffirms Their Buy Rating on Haemonetics (HAE)
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
Haemonetics Announces EVP Josep Llorens' Retirement
Here's Why You Should Add HAE Stock to Your Portfolio Now
No Data